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Abstract
Disease progression modeling (DPM) using longitudinal data is a challenging machine learning task. Existing DPM
algorithms neglect temporal dependencies among measurements, make parametric assumptions about biomarker trajecto-
ries, do not model multiple biomarkers jointly, and need an alignment of subjects’ trajectories. In this paper, recurrent
neural networks (RNNs) are utilized to address these issues. However, in many cases, longitudinal cohorts contain
incomplete data, which hinders the application of standard RNNs and requires a pre-processing step such as imputation
of the missing values. Instead, we propose a generalized training rule for the most widely used RNN architecture, long
short-term memory (LSTM) networks, that can handle both missing predictor and target values. The proposed LSTM
algorithm is applied to model the progression of Alzheimer’s disease (AD) using six volumetric magnetic resonance
imaging (MRI) biomarkers, i.e., volumes of ventricles, hippocampus, whole brain, fusiform, middle temporal gyrus, and
entorhinal cortex, and it is compared to standard LSTM networks with data imputation and a parametric, regression-based
DPM method. The results show that the proposed algorithm achieves a significantly lower mean absolute error (MAE)
than the alternatives with p < 0.05 using Wilcoxon signed rank test in predicting values of almost all of the MRI
biomarkers. Moreover, a linear discriminant analysis (LDA) classifier applied to the predicted biomarker values produces
a significantly larger area under the receiver operating characteristic curve (AUC) of 0.90 vs. at most 0.84 with p < 0.001
using McNemar’s test for clinical diagnosis of AD. Inspection of MAE curves as a function of the amount of missing data
reveals that the proposed LSTM algorithm achieves the best performance up until more than 74% missing values. Finally,
it is illustrated how the method can successfully be applied to data with varying time intervals. This paper shows that
built-in handling of missing values in training an LSTM network benefits the application of RNNs in neurodegenerative
disease progression modeling in longitudinal cohorts.
Keywords: Alzheimer’s disease, disease progression modeling, linear discriminant analysis, long short-term memory,
magnetic resonance imaging, recurrent neural networks.
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1. Introduction
Alzheimer’s disease (AD) is a chronic neurodegenera-
tive disorder that begins with memory loss and develops
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over time, causing issues in conversation, orientation, and
control of bodily functions (McKhann et al., 1984). Early
diagnosis of the disease is challenging and is usually made
once cognitive impairment has already compromised daily
living. Hence, developing robust, data-driven methods for
disease progression modeling (DPM) utilizing longitudi-
nal data is necessary to yield a complete perspective on
the disease for better diagnosis, monitoring, and prognosis
(Oxtoby and Alexander, 2017).
Existing longitudinal DPM methods model biomarkers
as a function of disease progression using continuous curve
fitting. In the AD progression modeling literature, a variety
of regression-based methods have been proposed to fit lo-
gistic or polynomial functions to the longitudinal dynamic
of each biomarker (Jedynak et al., 2012; Fjell et al., 2013;
Oxtoby et al., 2014; Donohue et al., 2014; Yau et al., 2015;
Guerrero et al., 2016). However, parametric assumptions
on the biomarker trajectories not only limit the flexibility
of such methods but also lead to the necessity of aligning
subjects’ trajectories. In addition, the existing approaches
mostly rely on independent biomarker modeling, and none
of them consider the temporal dependencies among mea-
surements.
Recurrent neural networks (RNNs) are non-parametric
sequence based learning methods that, by design, do not
require alignment of subject trajectories. They offer con-
tinuous, joint modeling of longitudinal data while taking
temporal dependencies among measurements into account
(Pearlmutter, 1989). Long short-term memory (LSTM)
networks, the most widely used type of RNNs, developed
to effectively capture long-term temporal dependencies by
dealing with the exploding and vanishing gradient prob-
lem during backpropagation through time (Hochreiter and
Schmidhuber, 1997; Gers et al., 1999; Gers and Schmid-
huber, 2001). They employ a memory cell with nonlinear
reset units – so called constant error carousels (CECs) –
and learn to store history for either long or short time peri-
ods. Since their introduction, a variety of LSTM networks
have been developed for different time-series applications
(Greff et al., 2017). The vanilla LSTM that utilizes three
reset gates with full gate recurrence is the most commonly
used LSTM architecture. It applies the backpropagation
through time algorithm using full gradients to train the net-
work and can include biases and cell-to-gates (peephole)
connections.
However, since longitudinal cohorts often contain miss-
ing biomarker values due to, for instance, dropped out
patients, unsuccessful measurements, or different assess-
ment patterns used for different subject groups – as seen in
the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
(Petersen et al., 2010), standard RNNs inclunding LSTMs
cannot be directly applied. Pre-processing methods such
as data imputation and interpolation are the most common
approaches to handling missing data in RNNs. These two-
step procedures decouple missing data handling and net-
work training, resulting in a sub-optimal performance that
is heavily influenced by the choice of data pre-processing
method (Lipton et al., 2016). Although RNNs themselves
have been used for estimating missing data (Parveen and
Green, 2002; Yoon et al., 2018), the lack of methods to
inherently handle incomplete data in RNNs is evident (Che
et al., 2018). Other approaches update the architecture to
learn or encode the missing data patterns (Che et al., 2018;
Lipton et al., 2016). These methods are typically biased
towards specific cohort or demographic circumstances cor-
related with the learned missing data patterns and introduce
additional parameters in the network which increases the
complexity of the network.
In this paper, we propose a generalized method for train-
ing LSTM networks that can handle missing values in both
input and target. This is achieved by applying the batch
gradient descent algorithm in combination with the loss
function and its gradients normalized by the number of
missing values in input and target. Our goal is different
than the approaches that encode the missing values’ pat-
terns (Che et al., 2018; Lipton et al., 2016); we want to
train RNNs robust to missing values to more faithfully
capture the true underlying signal and to make the learned
model generalizable across cohorts. The proposed LSTM
algorithm is applied to AD progression modeling in the
ADNI cohort (Petersen et al., 2010) based on volumetric
magnetic resonance imaging (MRI) biomarkers, and the
estimated biomarker values are used to predict the clinical
status of subjects. MRI is known to be the best noninva-
sive way to examine changes in the brain in vivo during
the course of AD (Biagioni and Galvin, 2011; Wu et al.,
2011), and volumetric analysis is a widely used ROI-based
method to estimate brain atrophy.
The main contribution is three-fold and can be summa-
rized as follows:
• First, a generalized formulation of backpropagation
through time for LSTM networks is proposed to han-
dle incomplete data, and it is shown that such built-in
handling of missing values provides a better modeling
and prediction performance compared to using data
imputation with standard LSTM networks.
• Second, temporal dependencies among measurements
in the ADNI data are modeled using the proposed
LSTM network via sequence-to-sequence learning.
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Figure 1: Illustration of how the normalization factors are related to the input and output of an unfolded RNN. Assume an RNN with three
consecutive time points {t− 1, t, t+ 1}, three input nodes, four hidden nodes, and two output nodes. Missing data for an instance observation j is
illustrated as black nodes. We wish to weight the loss function and its gradients according to the number of available points in the input and output
nodes. In this specific example, subject j has only one measurement available for its n-th input node and the same many for its m-th output node.
Hence, the loss function and its gradients are weighted by 1/3. Moreover, since there is a total of five measurements available in the input layer, the
loss function is weighted by 5/9. The later weighting factor is to ensure that the loss function takes the number of available points in the input layer
into account.
To the best of our knowledge, this is the first time
such multi-dimensional sequence learning methods
are applied to neurodegenerative DPM.
• Third, an end-to-end approach, without need for tra-
jectory alignment, is proposed for modeling the lon-
gitudinal dynamics of imaging biomarkers and for
clinical status prediction. This is a practical way of
implementing a robust DPM for both research and
clinical applications.
A preliminary version of this work appeared in proceed-
ings of the International Conference on Medical Imaging
with Deep Learning (Mehdipour Ghazi et al., 2018). The
present study contains a more detailed presentation and ad-
ditional experiments to investigate statistical significance,
robustness as a function of amount of missing data, and
situations with varying time steps.
2. Proposed LSTM algorithm
The main goal of this study is to minimize the influence
of missing values on the learned LSTM network parame-
ters. This is achieved by using the batch gradient descend
method in combination with the backpropagation through
time algorithm modified to take into account missing val-
ues in the input and target vectors. More specifically, the
algorithm sets input missing values to zero, backpropagates
zero errors corresponding to the target missing points, and
uses an L2-norm loss function with residuals weighted
according to the number of available time points per target
biomarker node (βjm) and according to the total number
of available input values for all visits of all biomarkers
(βjx). In addition, it normalizes input weight gradients of
the loss function according to the number of available time
points per input biomarker node (βjn). Figure 1 provides
an illustration of how the normalization factors are related
to the input and output of an unfolded RNN. Note that the
use of batch gradient descend ensures the availability of at
least one data point per biomarker that can proportionally
contribute in the weight update rule.
2.1. The basic LSTM architecture
Figure 2 shows a typical schematic of a vanilla LSTM
architecture. As can be seen, the topology includes a mem-
ory cell, an input modulation gate, and three nonlinear
reset gates, namely input gate, forget gate, and output gate,
each of which accepting current and recurrent inputs. The
memory cell learns to maintain its state over time while
the multiplicative gates learn to open and close access to
the constant error/information flow, to prevent exploding
or vanishing gradients. The input gate protects the memory
contents from perturbation by irrelevant inputs, and the
output gate protects other units from perturbation by cur-
rently irrelevant memory contents. The forget gate deals
with continual or very long input sequences, and finally,
peephole connections allow the gates to access the CEC of
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Figure 2: An illustration of a vanilla LSTM unit with peephole connec-
tions in red. The solid and dashed lines show weighted and unweighted
connections, respectively.
the same cell state.
2.2. Feedforward in LSTM networks
Assume xtj ∈ RN×1 is the j-th observation of an N -
dimensional input vector at current time t. If M is the
number of output units, feedforward calculations of the
LSTM network under study can be summarized as
f tj =Wfx
t
j + Ufh
t−1
j + Vf  ct−1j + bf ,
f˜ tj = σg(f
t
j ) ,
itj =Wix
t
j + Uih
t−1
j + Vi  ct−1j + bi ,
i˜tj = σg(i
t
j) ,
ztj =Wcx
t
j + Uch
t−1
j + bc ,
z˜tj = σc(z
t
j) ,
ctj = f˜
t
j  ct−1j + i˜tj  z˜tj ,
c˜tj = σh(c
t
j) ,
otj =Wox
t
j + Uoh
t−1
j + Vo  ctj + bo ,
o˜tj = σg(o
t
j) ,
htj = o˜
t
j  c˜tj ,
where {f tj , itj , ztj , ctj ,otj ,htj} ∈ RM×1 and
{f˜ tj , i˜tj , z˜tj , c˜tj , o˜tj} ∈ RM×1 are j-th observation of
forget gate, input gate, modulation gate, cell state, output
gate, and hidden output at time t before and after activation,
respectively. Moreover, {Wf ,Wi,Wo,Wc} ∈ RM×N
and {Uf , Ui, Uo, Uc} ∈ RM×M are sets of connecting
weights from current and recurrent inputs to the gates
and cell, respectively, {Vf ,Vi,Vo} ∈ RM×1 is the
set of peephole connections from the cell to the gates,
{bf , bi, bo, bc} ∈ RM×1 represents corresponding biases
of neurons, and  denotes element-wise multiplication.
Finally, σg, σc, and σh are nonlinear activation functions
assigned for the gates, input modulation, and hidden
output, respectively. Logistic sigmoid functions are
applied to the gates with range [0, 1] while hyperbolic
tangent functions are applied to modulate both cell
input and hidden output with range [−1, 1]. Hence, the
measurements need to be in the same range [−1, 1].
2.3. Robust backpropagation through time
Let L ∈ RM×1 be the loss function defined based on
the actual target s and network output y. Here, we con-
sider one layer of LSTM units for sequence learning which
means that the network output is the hidden output. The
main idea is to calculate the partial derivatives of the nor-
malized loss function (δ) with respect to the weights using
the chain rule.
L(m) = 1
2JT
∑
j,t
1
βjxβ
j
m
(ytj(m)− stj(m))2 ,
δytj(m) =
1
JT
[ 1
βjxβ
j
m
(ytj(m)− stj(m))
]
,
where βjx =
|xj |
TN and β
j
m =
|yj(m)|
T are normalization
factors to handle missing values of the j-th observation
with batch size J and sequence length T . Also, |xj | and
|yj(m)| denote the total number of available input values
and the number of available target time points in the m-
th node, respectively. The backpropagation calculations
through time using full gradients can be obtained as
δhtj = U
T
f δf
t+1
j + U
T
i δi
t+1
j + U
T
c δz
t+1
j + U
T
o δo
t+1
j
+ δytj ,
δo˜tj = δh
t
j  c˜tj ,
δotj = δo˜
t
j  σ′g(otj) ,
δc˜tj = δh
t
j  o˜tj ,
δctj = Vf  δf t+1j + Vi  δit+1j + Vo  δotj
+ δc˜tj  σ′h(ctj) + δct+1j  f˜ t+1j ,
δz˜tj = δc
t
j  i˜tj ,
δztj = δz˜
t
j  σ′c(ztj) ,
δi˜tj = δc
t
j  z˜tj ,
δitj = δi˜
t
j  σ′g(itj) ,
δf˜ tj = δc
t
j  ct−1j ,
δf tj = δf˜
t
j  σ′g(f tj ) ,
δxtj =W
T
f δf
t
j +W
T
i δi
t
j +W
T
c δz
t
j +W
T
o δo
t
j ,
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Finally, if θ ∈ {f, i, z, o} and φ ∈ {f, i}, the gradi-
ents of the loss function with respect to the weights are
calculated as
δWθ(n) =
J∑
j=1
1
βjn
δθ
{0→T}
j x
{0→T}
j (n) ,
δUθ =
J∑
j=1
δθ
{1→T}
j h
{0→T−1}
j ,
δVφ =
J∑
j=1
T−1∑
t=0
δφt+1j  ctj ,
δVo =
J∑
j=1
T∑
t=0
δotj  ctj ,
δbθ =
J∑
j=1
T∑
t=0
δθtj ,
where βjn =
|xj(n)|
T is the normalization factor handling
missing input values and |xj(n)| is the number of avail-
able time points in the input’s n-th node. Here, we use a
fixed sequence length of T to proportionally consider sub-
jects based on their available visits. However, the robust
backpropagation algorithm can easily be generalized for a
dynamic sequence length.
2.4. Momentum batch gradient descent
As an efficient iterative algorithm, momentum batch
gradient descent is applied to find the local minimum of
the loss function calculated over a batch while speeding up
the convergence. The update rule using L2 regularization
can be written as
ϑnew = µϑold − α(δω + γωold) ,
ωnew = ωold + ϑnew ,
where ϑ is the weight update initialized to zero, ω is the
to-be-updated weight array, δω is the gradient of the loss
function with respect to ω, and α, γ, and µ are the learning
rate, weight decay or regularization factor, and momentum
weight, respectively.
3. Experiments
3.1. Data
Data used in the preparation of this article is obtained
from the ADNI database. The ADNI was launched in
2003 as a public-private partnership, led by principal in-
vestigator Michael W. Weiner, MD. The primary goal of
ADNI has been to test whether serial magnetic resonance
imaging, positron emission tomography, other biological
markers, and clinical and neuropsychological assessment
can be combined to measure the progression of mild cog-
nitive impairment and early Alzheimer’s disease. To be
more specific, we use The Alzheimer’s Disease Prediction
Of Longitudinal Evolution (TADPOLE) challenge dataset
(Marinescu et al., 2018) which is composed of data from
the three ADNI phases ADNI 1, ADNI GO, and ADNI
2. This includes roughly 1,500 biomarkers acquired from
1,737 subjects (957 males and 780 females) during 12,741
visits at 22 distinct time points between 2003 and 2017.
Table 1 summarizes statistics of the demographics in the
TADPOLE dataset. Note that the subjects include missing
values and clinical status during their visits.
In this work, we have merged existing groups labeled
as cognitively normal (CN), significant memory concern
(SMC), and normal (NL) under CN, mild cognitive impair-
ment (MCI), early MCI (EMCI), and late MCI (LMCI)
under MCI, and Alzheimer’s disease (AD) and dementia
under AD. Moreover, groups with labels converting from
one status to another, e.g. MCI-to-AD, belong to the next
status (AD in this example).
MRI biomarkers are used for AD progression modeling.
This includes T1-weighted brain MRI volumes of ventri-
cles, hippocampus, whole brain, fusiform, middle temporal
gyrus, and entorhinal cortex. We normalize the MRI mea-
surements by the corresponding intracranial volume (ICV).
Next, we filter within-class outliers of each biomarker –
across all subjects and their visits – by assuming them as
missing values and normalize the measurements by scal-
ing them linearly to [−1, 1]. Out of 22 visits, we initially
select 11 regular visits with a fixed interval of one year
including baseline. Finally, subjects with less than three
distinct visits for any biomarker are removed to obtain
742 subjects. This is to ensure that at least two visits are
available per biomarker for performing sequence learning
through the feedforward step and an additional visit for
backpropagation.
For evaluation purpose, we partition the entire dataset
to three non-overlapping subsets for training, validation,
and testing. To achieve this, we randomly select 10%
of the within-class subjects for validation and the same
for testing. More specifically, we randomly pick subjects
based on their baseline labels while ensuring that subjects
with few and large number of visits are included in each
subset. This process results in 592, 76, and 74 subjects for
training, validations, and testing, respectively. Details on
the amount of available visits in the obtained evaluation
subsets are shown in Table 2. As can be deduced from the
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Table 1: Demographics of the TADPOLE dataset.
Number of visits Age, year (mean±SD) Education, year (mean±SD)
male female male female male female
CN 1,356 1,389 76.67±6.44 75.85±6.28 17.06±2.51 15.74±2.71
MCI 2,454 1,604 75.59±7.47 73.87±8.09 16.22±2.85 15.45±2.76
AD 1,208 900 77.22±7.11 75.45±7.92 15.85±3.03 14.35±2.73
All (labeled & unlabeled) 12,741 76.00±7.38 15.91±2.86
table, 63% of the obtained data is missing.
3.2. Evaluation metrics and statistical tests
Mean absolute error (MAE) and multi-class area under
the receiver operating characteristic (ROC) curve (AUC)
are used to assess the performance of modeling and classi-
fication, respectively. MAE measures accuracy of contin-
uous prediction per biomarker by computing the absolute
difference between actual and estimated values as follows
MAE =
1
I
∑
j,t
|ytj − stj | ,
where stj and y
t
j are the ground-truth and estimated values
of the specific biomarker for the j-th subject at the t-th
visit, respectively, and I is the number of available points
in the target array s.
Multi-class AUC (Hand and Till, 2001) is a measure to
examine the diagnostic performance in a multi-class test
set using ROC analysis. It is calculated using the posterior
probabilities as follows
AUC =
1
(nc(nc − 1))
nc−1∑
i=1
nc∑
k=i+1
1
nink
×
[
SRi − ni(ni + 1)
2
+ SRk − nk(nk + 1)
2
]
,
where nc is the number of distinct classes, ni denotes the
number of available points belonging to the i-th class, and
SRi is the sum of the ranks of posteriors p(ci|si) after
sorting all concatenated posteriors {p(ci|si), p(ci|sk)} in
an ascending order, where si and sk are vectors of scores
belonging to the true classes ci and ck, respectively.
The modeling performance is statistically assessed for
different methods using the paired, two-sided Wilcoxon
signed rank test (Wilcoxon, 1945) applied to the obtained
absolute errors. Also, classification performance is an-
alyzed using McNemar’s test (McNemar, 1947) applied
to the hard classification results (clinical status) obtained
from a linear discriminant analysis (LDA) classifier with
predicted MRI measurements as input.
3.3. Experimental setup
The following methods are evaluated in our conducted
experiments:
• LSTM-Robust: an LSTM network trained based on
the proposed robust backpropagation through time
algorithm by setting input missing values to zero and
backpropagating zero errors corresponding to the tar-
get missing points while training.
• LSTM-Mean: an LSTM network trained using the
standard backpropagation through time algorithm
with missing values imputed based on mean impu-
tation method prior to training (Che et al., 2018).
• LSTM-Forward: an LSTM network trained using
the standard backpropagation through time algorithm
with missing values imputed based on forward impu-
tation method prior to training (Lipton et al., 2016).
• Regression-Based: a parametric, regression-based
method (Jedynak et al., 2012) that automatically han-
dles missing values. The parameters of the algorithm
are initially estimated using linear regression in 15
iterations and are optimized using sigmoidal func-
tions in 35 additional iterations where all parameters
converge.
All the methods are developed in MATLAB R2017b
and run on a 2.80 GHz CPU with 16 GB RAM. We initial-
ize the LSTM networks’ weights by generating uniformly
distributed random values in range [−0.05, 0.05] and set
the weights’ updates and weights’ gradients to zero. The
batch size is set to the number of available training subjects,
and the first ten visits are used to estimate the second to
eleventh visits per subject for evaluation purpose. It should
be noted that when data imputation is applied, the robust
backpropagation formulas simply generalize to the ones
for the standard LSTM network.
We utilize the validation set to tune all the networks’
optimization parameters, each time by adjusting one of the
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Table 2: Number of visits in the evaluation subsets across all subjects. Note that the complete dataset should have contained 742× 11 = 8, 162
visits per biomarker where the maximum number of visits per subject is 11. The number of visits per subject per diagnostic group is left blank as
subjects can convert from one group to another in the course of AD.
Number of visits across subjects Number of visits per subject (mean±SD ∼ [min, max])
train / validation / test train / validation / test
CN 1,192 / 136 / 149
MCI 1,389 / 198 / 180
AD 606 / 84 / 92
C
lin
ic
al
la
be
ls
All (labeled & unlabeled) 3,270 / 428 / 434 5.52±2.32 ∼ [3, 11] / 5.63±2.39 ∼ [3, 11] / 5.86±2.51 ∼ [3, 11]
Ventricles 2,481 / 328 / 318 4.19±1.47 ∼ [3, 10] / 4.32±1.46 ∼ [3, 8] / 4.30±1.58 ∼ [3, 9]
Hippocampus 2,381 / 311 / 312 4.02±1.31 ∼ [3, 10] / 4.09±1.29 ∼ [3, 8] / 4.22±1.49 ∼ [3, 7]
Whole brain 2,513 / 328 / 322 4.24±1.49 ∼ [3, 10] / 4.32±1.46 ∼ [3, 8] / 4.35±1.57 ∼ [3, 9]
Entorhinal cortex 2,351 / 310 / 309 3.97±1.29 ∼ [3, 10] / 4.08±1.34 ∼ [3, 8] / 4.18±1.46 ∼ [3, 7]
Fusiform 2,351 / 310 / 309 3.97±1.29 ∼ [3, 10] / 4.08±1.34 ∼ [3, 8] / 4.18±1.46 ∼ [3, 7]
M
R
Ib
io
m
ar
ke
rs
Middle temporal gyrus 2,351 / 309 / 309 3.97±1.29 ∼ [3, 10] / 4.07±1.35 ∼ [3, 8] / 4.18±1.46 ∼ [3, 7]
parameters while keeping the rest at fixed values to achieve
the lowest average MAE. Peephole connections are used in
the networks since they tend to improve the performance
(Greff et al., 2017). Based on these strategies, the optimal
parameters are obtained as α = 0.1, µ = 0.9, and γ =
0.0001 with 1,000 epochs. The corresponding MAEs for
the validation set are also calculated as 0.00296, 0.00025,
0.01494, 0.00024, 0.00076, and 0.00097, for ventricles,
hippocampus, whole brain, entorhinal cortex, fusiform,
and middle temporal gyrus, respectively. It takes about
340 seconds to train the network and 0.025 seconds to
estimate all the validation measurements. It is worthwhile
mentioning that all the estimated measurements are linearly
scaled from [−1, 1] to the original range of biomarkers
using the original minimum and maximum values while
calculating MAEs.
4. Results and discussion
After successfully training the LSTM networks and the
regression-based method for DPM, they are all evaluated
using the test set.
4.1. Biomarker modeling
Table 3 compares the test MRI biomarker modeling per-
formance (MAE) using aforementioned methods. Even
though the performance is reported per biomarker, the
models are jointly fitted to all biomarkers. As it can be
deduced from Table 3, LSTM-Robust significantly outper-
forms the other methods in all MRI biomarkers except for
whole brain where the regression-based approach performs
significantly better and for middel temporal gyrus where
there is no difference between the proposed method and
LSTM-Forward.
4.2. Predicting clinical status
To assess the ability of the estimated measurements in
predicting the clinical status, we train an LDA classifier
using the estimated training measurements and apply it
to the estimated test data to compute the posterior prob-
abilities. The obtained scores are then used to calculate
diagnostic AUCs. The diagnostic prediction results for
the test set are shown in Table 4. As can be seen, LSTM-
Robust outperforms all other methods in predicting clinical
status of subjects per visit with a multi-class AUC of 0.76,
which reveals the effect of modeling on classification per-
formance. One could of course use other classifiers or
train the LSTM network directly for classification based
on sequence-to-label learning to potentially improve the
diagnostic AUCs. However, the focus of this work is on
DPM based on sequence-to-sequence learning. In addition,
sequence-to-label learning would only be able to utilize
the part of the training data which has available clinical
status.
The multi-class AUC of 0.76 obtained using predicted
measurements from the proposed approach is within the
top-five AUCs of the state-of-the-art, cross-sectional MRI-
based classification results of the recent challenge on
Computer-Aided Diagnosis of Dementia (CADDementia)
(Bron et al., 2015) that ranged from 0.75 to 0.79. It should,
however, be noted that there are important differences be-
tween this study and the CADDementia challenge. Firstly,
this work has the advantage of training and testing data
from the same cohort whereas CADDementia algorithms
were applied to classify data from independent cohorts.
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Table 3: Test MRI biomarker modeling performance (MAE) for yearly predictions. The proposed method is compared with the alternatives
using a paired, two-sided Wilcoxon signed rank test, and this is reported in superscript as LSTM-Robust vs. LSTM-Mean/LSTM-Robust vs.
LSTM-Forward/LSTM-Robust vs. Regression-Based. † : not significantly different, ? : p < 0.05, ?? : p < 0.01, ? ? ? : p < 0.001.
LSTM-Robust LSTM-Mean LSTM-Forward Regression-Based
(Che et al., 2018) (Lipton et al., 2016) (Jedynak et al., 2012)
Ventricles 0.00307???/???/??? 0.00620 0.00472 0.00807
Hippocampus 0.00023???/??/??? 0.00051 0.00034 0.00051
Whole brain 0.01330???/??/??? 0.02375 0.01639 0.00551
Entorhinal cortex 0.00021???/?/??? 0.00030 0.00025 0.00035
Fusiform 0.00068???/???/??? 0.00130 0.00100 0.00090
Middle temporal gyrus 0.00087???/†/? 0.00126 0.00118 0.00111
Table 4: Test diagnostic performance (AUC) of the estimated MRI biomarker values using an LDA classifier. The proposed method is compared
with the alternatives using McNemar’s test, and this is reported in superscript as LSTM-Robust vs. LSTM-Mean/LSTM-Robust vs. LSTM-
Forward/LSTM-Robust vs. Regression-Based. † : not significantly different, ? : p < 0.05, ?? : p < 0.01, ? ? ? : p < 0.001.
LSTM-Robust LSTM-Mean LSTM-Forward Regression-Based
(Che et al., 2018) (Lipton et al., 2016) (Jedynak et al., 2012)
CN vs. MCI 0.5914†/†/† 0.5838 0.5800 0.5468
CN vs. AD 0.9029???/???/??? 0.8404 0.8150 0.7826
MCI vs. AD 0.7844†/†/† 0.6936 0.6890 0.7330
CN vs. MCI vs. AD 0.7596†/?/? 0.7059 0.6947 0.6875
Secondly, the top performing CADDementia algorithms
incorporated different types of MRI biomarkers besides
volumetry. Thirdly, this work predicts the input features to
the classifier based on historical longitudinal data.
4.3. Robustness as a function of amount of missing data
To evaluate the modeling robustness of the proposed
method compared to the alternatives for different amounts
of missing data, we construct subsamples of the training
dataset by randomly removing up to 50% of the actual
data per biomarker and train the methods on the smaller
datasets. Figure 3 illustrates the modeling performance of
the different methods on various amounts of missing mea-
surements, from 0% to 50%. It is important to note that the
training data already includes a large number of missing
values at missing rate of 0% – i.e. 63% of actual data as
seen on Table 2. For better comparison, we take the aver-
age of MAEs normalized by the range of corresponding
biomarkers to obtain a single curve per method. As can be
seen, the result of the proposed method is superior to those
of the benchmarks up until missing around 74% of the
data. For higher rates of missing data, basic LSTM with
forward imputation outperforms all other methods. One
reason for why LSTM with forward imputation is robust
to the higher rates of missing data could be due to the fact
that it replaces the missing values placed at the beginning
of a sequence with the whole training data median.
4.4. Irregular time intervals
As final experiment, we assess generalizability of the
proposed method for predicting measurements of irregular
visits. In general, standard LSTM networks are designed
to handle evenly spaced sequences. We used the same
approach in our baseline experiments for AD progression
modeling application by disregarding visiting months 3, 6
and 18, and confined the experiments to yearly follow-up
in the ADNI data. Now, we employ the available mea-
surements of the 6-th and 18-th visiting months from the
TADPOLE dataset and predict biomarker values of half-
yearly follow-ups by assuming unavailable visits as miss-
ing data. In this experiment, 78% of the actual data is
missing. We apply the same methods to the extended data.
Table 5 details the test modeling performance of the MRI
biomarkers for half-yearly predictions using the different
DPM methods. As can be seen, our proposed DPM method
outperforms all other methods in all categories. More inter-
estingly, considering the corresponding results from Table
3 for yearly predictions, one can deduce that the modeling
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Table 5: Test MRI biomarker modeling performance (MAE) for half-yearly predictions.
LSTM-Robust LSTM-Mean LSTM-Forward Regression-Based
(Che et al., 2018) (Lipton et al., 2016) (Jedynak et al., 2012)
Ventricles 0.00272 0.00973 0.01030 0.00659
Hippocampus 0.00023 0.00068 0.00065 0.00043
Whole brain 0.01181 0.03332 0.02552 0.00601
Entorhinal cortex 0.00021 0.00037 0.00032 0.00038
Fusiform 0.00061 0.00164 0.00196 0.00091
Middle temporal gyrus 0.00085 0.00220 0.00263 0.00097
63 65 67 69 71 73 75 77 79 81
Amount of Missing Data (%)
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Figure 3: Modeling performance of MRI biomarkers for various
amounts of missing values.
performance of the proposed method improves by utilizing
the irregular visits. However, the additional time points in
the LSTM increases the required time for training and vali-
dation to 1,090 seconds and 0.061 seconds, respectively.
As an alternative, one could utilize modified LSTM
architectures where the networks learn a number of param-
eters to encode visiting patterns among longitudinal patient
records (Baytas et al., 2017; Neil et al., 2016). However,
using such methods not only increase the complexity of the
network but also risk learning any time spacing patterns in
the data.
5. Conclusions
In this paper, a training algorithm was proposed for
LSTM networks aiming to improve robustness against
missing data, and the robustly trained LSTM network was
applied to AD progression modeling using longitudinal
measurements of MRI biomarkers. To the best of our
knowledge, this is the first time RNNs have been stud-
ied and applied to DPM within neurodegenerative disease.
Moreover, since RNNs are non-parametric learning meth-
ods, the proposed approach can be applied to different time-
series data and characteristics than the monotonic behavior
that one typically encounters in MRI-based neurodegener-
ative disease progression modeling. The proposed training
method demonstrated better performance than using im-
putation prior to standard LSTM network training and
outperformed an established parametric, regression-based
DPM method in terms of both biomarker prediction and
subsequent diagnostic classification. This method is also
applicable for other types of RNNs such as gated recurrent
units (GRUs) (Cho et al., 2014). This study highlights the
potential of RNNs for modeling the progression of AD us-
ing longitudinal measurements, provided that proper care
is taken to handle missing values and time intervals.
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